Christine Blancher

Christine Blancher has a wealth of professional experience in the scientific, technology, and healthcare sectors. Christine began their career in 1996, working as a Post-Doctoral Research Scientist at Cancer Research UK, Oxford University. There, they studied the role of the hypoxic response pathway in tumour biology. In 2000, they moved to INSERM U450, Development, Ageing and Pathology of Neuroretina, where they worked on the “Role and regulation of the Proliferation Arrest Transcription Factor (PATF) on cell cycle withdrawal.”

In 2001, they joined Peter MacCallum Cancer Centre, Melbourne University, as a Senior Scientific Officer in Breast and Ovarian Cancer Genetics. Christine worked on the “Molecular and functional analysis of ST7 tumour suppressor and assessment of its role in the development of breast, ovarian and colorectal cancers.”

From 2002 to 2020, Christine Blancher worked at the Wellcome Trust Centre for Human Genetics, University of Oxford, in a number of roles. These included Genomic Service Manager, Consultant & Senior Project Manager at the Oxford Genomic Centre, Senior Post-Doctoral Scientist Research & Development at Core Genomics, and Senior Post-Doctoral Research Scientist at Diabetes Genetics.

In 2020, Christine Blancher joined the Department of Health and Social Care as a Technology Expert for the Devolved Administrations - UK COVID-19 Mass Testing Program. In this role, they provided daily updates, scientific expertise, and strategic support to government and scientific leads.

Most recently, in 2021, Christine Blancher began working at Depixus as the Head of Applications and Collaborations.

Christine Blancher began their educational journey in 1987 when they obtained a Bachelor of Science (BSc) from Universite Paris VI - Pierre et Marie Curie in Cellular Biology, with a speciality in Genetics. In 1990, they earned a Master of Science (MSc) from Universite Paris V - Rene Descartes in Biology of Normal and Abnormal Cells. Finally, in 1996, they completed their education with a Doctor of Philosophy (PhD) from Universite Paris V - Rene Descartes in Cellular and Molecular Biology.